Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Belle Health vs Vitara RX

Belle Health
Graded #75

Lower grade

vs+12.2
Vitara RX
Graded #12

Higher grade

The verdict

Vitara RX takes it — 86/100 to 73.8/100.

Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitara RX +1
92
93
Dose & formulationVitara RX +8
72
80
Clinical oversightVitara RX +30
55
85
Labs & monitoringVitara RX +11
72
83
FulfillmentVitara RX +2
85
87
Contract termsVitara RX +31
55
86
Belle Health · left barVitara RX · right bar

The numbers

MetricBelle HealthVitara RX
WeighScore73.8/10086/100
GradeCB
Scorecard rank#75#12
SemaglutideFrom $109/mo (compounded; supply terms unverified)$99/mo
TirzepatideFrom $179/mo (compounded; supply terms unverified)$149/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Belle Health

Graded #75 · C

FDAWarning letter issued to Belle Health LLC dba Belle in February 2026. See the FDA warning-letter database.

Strengths

  • Weekly live group sessions with a named registered dietitian are included
  • Provider review, nurse support, injection supplies and shipping are included
  • Advertises the same price across dose levels
  • Terms state telehealth availability in all 50 states

Where it loses points

  • Starting prices do not establish the required supply length, upfront charge or renewal amount
  • Compounded medications are not FDA-approved finished products
  • Prescription products are nonrefundable after shipment; subscriptions may renew automatically
  • FDA issued Belle Health LLC dba Belle a warning letter in February 2026; the letter is public in FDA's warning-letter database
Vitara RX

Graded #12 · B

Strengths

  • $99 sema / $149 tirz — bottom-quartile pricing
  • Both molecules, all 50 states
  • LegitScript-verified

Where it loses points

  • Injection-only, no oral route
  • Labs/monitoring not detailed
  • Newer, thinner track record

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard